The regulation of MDM2 oncogene and its impact on human cancers

被引:132
|
作者
Zhao, Yuhan [1 ]
Yu, Haiyang [1 ]
Hu, Wenwei [1 ,2 ]
机构
[1] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pediat, Dept Pharmacol, New Brunswick, NJ 08903 USA
基金
美国国家卫生研究院;
关键词
MDM2; E3 ubiquitin ligase; gene regulation; p53; TUMOR-SUPPRESSOR PATHWAY; P53-MDM2 FEEDBACK LOOP; UBIQUITIN LIGASE ACTIVITY; RIBOSOMAL-PROTEIN L26; LI-FRAUMENI-SYNDROME; DNA-DAMAGE; ACTIVATES P53; MUTANT P53; P53-DEPENDENT MANNER; ONCOPROTEIN MDM2;
D O I
10.1093/abbs/gmt147
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tumor suppressor p53 plays a central role in preventing tumor formation. The levels and activity of p53 is under tight regulation to ensure its proper function. Murine double minute 2 (MDM2), a p53 target gene, is an E3 ubiquitin ligase. MDM2 is a key negative regulator of p53 protein, and forms an auto-regulatory feedback loop with p53. MDM2 is an oncogene with both p53-dependent and p53-independent oncogenic activities, and often has increased expression levels in a variety of human cancers. MDM2 is highly regulated; the levels and function of MDM2 are regulated at the transcriptional, translational and post-translational levels. This review provides an overview of the regulation of MDM2. Dysregulation of MDM2 impacts significantly upon the p53 functions, and in turn the tumorigenesis. Considering the key role that MDM2 plays in human cancers, a better understanding of the regulation of MDM2 will help us to develop novel and more effective cancer therapeutic strategies to target MDM2 and activate p53 in cells.
引用
收藏
页码:180 / 189
页数:10
相关论文
共 50 条
  • [41] Regulation of p53 stability by Mdm2
    Kubbutat, MHG
    Jones, SN
    Vousden, KH
    NATURE, 1997, 387 (6630) : 299 - 303
  • [42] Regulation of p53 stability by Mdm2
    Michael H. G. Kubbutat
    Stephen N. Jones
    Karen H. Vousden
    Nature, 1997, 387 : 299 - 303
  • [43] Function and dysfunction of the human oncoprotein MDM2
    Deb, SP
    FRONTIERS IN BIOSCIENCE, 2002, 7 : D235 - D243
  • [44] Stimulation of human DNA polymerase ε by MDM2
    Asahara, H
    Li, Y
    Fuss, J
    Haines, DS
    Vlatkovic, N
    Boyd, MT
    Linn, S
    NUCLEIC ACIDS RESEARCH, 2003, 31 (09) : 2451 - 2459
  • [45] Mdm2 Phosphorylation Regulates Its Stability and Has Contrasting Effects on Oncogene and Radiation-Induced Tumorigenesis
    Carr, Michael I.
    Roderick, Justine E.
    Gannon, Hugh S.
    Kelliher, Michelle A.
    Jones, Stephen N.
    CELL REPORTS, 2016, 16 (10): : 2618 - 2629
  • [46] Preferential expression of Mdm2 oncogene during the development of neural crest and its derivatives in mouse early embryogenesis
    Daujat, S
    Neel, H
    Piette, J
    MECHANISMS OF DEVELOPMENT, 2001, 103 (1-2) : 163 - 165
  • [47] STRUCTURE AND ORGANIZATION OF AMPLIFIED DNA ON DOUBLE MINUTES CONTAINING THE MDM2 ONCOGENE
    FAKHARZADEH, SS
    ROSENBLUMVOS, L
    MURPHY, M
    HOFFMAN, EK
    GEORGE, DL
    GENOMICS, 1993, 15 (02) : 283 - 290
  • [48] Jmjd2c histone demethylase enhances the expression of Mdm2 oncogene
    Ishimura, Akihiko
    Terashima, Minoru
    Kimura, Hiroshi
    Akagi, Keiko
    Suzuki, Yutaka
    Sugano, Sumio
    Suzuki, Takeshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 389 (02) : 366 - 371
  • [49] The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor
    Manfredi, James J.
    GENES & DEVELOPMENT, 2010, 24 (15) : 1580 - 1589
  • [50] Evidence that the human cytomegalovirus IE2-86 protein binds mdm2 and facilitates mdm2 degradation
    Zhang, ZG
    Evers, DL
    McCarville, JF
    Dantonel, JC
    Huong, SM
    Huang, ES
    JOURNAL OF VIROLOGY, 2006, 80 (08) : 3833 - 3843